Abstract: A composition for relieving stress comprising a Bifidobacterium breve MCC 1274 (FERMBP-11175) as an active ingredient is provided. The composition for relieving stress according to the present technology can improve or prevent stress-induced anger, confusion, tension, or fatigue, or can improve vigor., stress can be assessed by POMS or POMS 2. The composition for relieving stress according to the present technology can be used for pharmaceutical compositions and food and drink compositions.

Abstract: A major object of the present technology is to provide a technology for obtaining an aloe extract which has an excellent processability into foods and contains sufficient amounts of ?-sitosterol and aloe-derived dietary fibers as functional components. The present technology provides a method for manufacturing an aloe extract containing ?-sitosterol, phospholipids, and dietary fibers which involves carrying out: a homogenization step for homogenizing an aloe mesophyll solution; an enzymatic degradation step for adding a polysaccharide-degrading enzyme to the homogenized aloe mesophyll solution and degrading polysaccharides contained in the aforementioned homogenized aloe mesophyll solution; and a membrane filtration step for membrane-filtering the enzyme-degraded aloe mesophyll solution with a microfiltration membrane or an ultrafiltration membrane and recovering the retentate fraction as an aloe extract.

Abstract: A kit for detecting live cells of a microorganism in a test sample by distinguishing the live cells from dead cells or injured cells by a nucleic acid amplification method includes the following components: 1) an agent capable of covalently binding to DNA or RNA of the microorganism by irradiation with light having a wavelength of 350 nm to 700 nm; 2) an agent for suppressing a nucleic acid amplification inhibitory substance; and 3) a primer or primers for amplifying a target region of the DNA or RNA of the microorganism to be detected by a nucleic acid amplification method. The agent for suppressing a nucleic acid amplification inhibitory substance is one or more selected from albumin, dextran, T4 gene 32 protein, acetamide, betaine, dimethyl sulfoxide, formamide, glycerol, polyethylene glycol, soybean trypsin inhibitor, ?2-macroglobulin, tetramethylammonium chloride, lysozyme, phosphorylase and lactate dehydrogenase.

Abstract: A novel agent useful for improving brain function is provided. The active ingredient in this agent is a Bifidobacterium breve and/or a Bifidobacterium breve-containing cultured material is provided.

Abstract: To provide a technology capable of promoting growth of Bifidobacterium bacteria and lactic acid bacteria under an environment causing the growth or no change in cell count while suppressing decrease under an environment causing the decrease. Provided is an agent for promoting the growth of, and/or suppressing a decrease in, Bifidobacterium bacteria and/or lactic acid bacteria containing Arthrospira blue-green algae and/or Spirulina blue-green algae as an active ingredient. Also provided is an oral composition including Arthrospira blue-green algae and/or Spirulina blue-green algae together with at least one type of bacteria selected from the group consisting of Bifidobacterium bacteria and lactic acid bacteria.

Abstract: An agent for protecting upper respiratory tracts or a food or drink composition for protecting upper respiratory tracts which is effective in ameliorating various symptoms relating to upper respiratory tracts is provided. An agent for protecting upper respiratory tracts and a food or drink composition for protecting upper respiratory tracts containing lactoferrin, lactoperoxidase, glucose oxidase, glucose source, and a pH adjusting component as active ingredients is provided. The agent for protecting an upper respiratory tract according to the present invention and the food or drink composition for protecting an upper respiratory tract can ameliorate various symptoms relating to upper respiratory tracts.

Abstract: The present disclosure provides a method for manufacturing an excellent denatured whey protein having no adverse effect on the characteristics of a product. A method for manufacturing a denatured whey protein comprising processing a whey protein solution by repeating the following steps (1) and (2) 2 times or more continuously: (1) a step for treating the whey protein solution on pressure at 50 MPa or higher and on heating at 85 to 100° C.; and, (2) a step for decompressing to 0.05 to 0.5 MPa after the treating of the aforementioned step (1) and maintaining the temperature within the range of the heating temperature of the aforementioned step (1) ±10° C.

Abstract: The Lactobacillus paracasei MCC1849 (NITE BP-01633) strain, which has a high IL-12 production-promoting action, is used as an ingredient of a drug, food or drink, or feed used for promotion of IL-12 production, immunostimulation, antivirus, or the like.

Abstract: A power control device supplies electrolysis voltage and electrolysis current, based on input direct-current power, to an electrolytic cell for manufacturing electrolysis water by electrolysis on a raw material solution by means of electric current applied between an anode and a cathode.

Abstract: The invention is a bipolar-electrode electrolytic cell (1) which includes a chassis (2), an electrode plate (3) and a plate-shape spacer (4) having a concavity (25) disposing the electrode plate (3), wherein an unit cell (C), which is formed by connecting a plurality of spacers (4) in which the electrode plate (3) is disposed on the concavity (25) so that one plate surface of the electrode plate (3) is directed to one direction, is disposed inside the chassis (2). The bipolar-electrode electrolytic cell (1) includes engaged portions (35, 50 and 51) which are provided on any one of the concavity (25) of the spacer (4) or the electrode plate (3) and engaging portions (10A and 10B) which are formed the other portion with respect to the one portion.

Abstract: The present invention relates to a method for manufacturing a modified whey composition, the method having a liquid preparation step of preparing a raw material whey liquid using a whey composition containing whey protein, and a heating step of subjecting the raw material whey liquid to a heat treatment, wherein the liquid preparation step includes a treatment of adding an alkali to the whey composition, the pH of the raw material whey liquid is from 6.8 to 8.0 and the protein concentration in the liquid is not more than 1.3% by mass, the calcium content of the raw material whey liquid that is subjected to the heat treatment is from 400 to 700 mg/100 g of solids, and the heat treatment is performed under conditions of 80 to 150° C. for a period of 30 minutes to 1 second.

Abstract: An extract of Citrus depressa, preferably a water and/or organic solvent extract of a fruit of leaf of Citrus depressa, a supercritical extract of a fruit of leaf of Citrus depressa, or a subcritical extract of a fruit of leaf of Citrus depressa, which comprise 0.3 mass % or more of a polymethoxyflavonoid more than in terms of solid matter, for example, an extract of Citrus depressa comprising 0.2 mass % or more of nobiletin and/or 0.1 mass % or more of tangeretin in terms of solid matter, or a polymethoxyflavonoid such as nobiletin or tangeretin is used as an active ingredient of an IGF-1 production-promoting agent.

Abstract: An electrolysis water-making apparatus (1) generates electrolyzed products by supplying a raw material solution into an electrolytic cell (4) to perform electrolysis, and generates electrolyzed water by diluting the electrolyzed products. The electrolysis water-making apparatus (1) includes a casing (20) configured to accommodate the electrolytic cell (4), and a bracket (30) fixed to the casing (20) in a freely detachable manner, and the bracket (30) includes a pair of rigid walls to which one end and the other end of the electrolytic cell (4) are attached. The pair of rigid walls have a dimension therebetween that can be adjusted according to the linear dimension of the electrolytic cell (4).

Abstract: An excellent peptidyl peptidase-IV inhibitor and the like are provided. A peptide consisting of Val-Pro-X wherein X represents an amino acid residue (except for L-proline residue); the aforementioned X is preferably one selected from a basic amino acid residue, an aliphatic neutral amino acid residue, an amide group-carrying neutral amino acid residue, or an aromatic group-carrying neutral amino acid residue; the aforementioned X is preferably one selected from an alanine residue, a glutamine residue, a methionine residue, an asparagine residue, a glycine residue, a valine residue, a tyrosine residue, a serine residue, and a lysine residue; a dipeptidyl peptidase-IV inhibitor, a blood sugar rise suppressing agent, a vascular endothelial disorder suppressing agent, and an angiotensin converting enzyme inhibitor containing the aforementioned peptide as an active ingredient.

Abstract: Live cells of a microorganism in a test sample are detected by the following steps: a) the step of treating the test sample with a topoisomerase poison and/or a DNA gyrase poison, b) the step of extracting DNA from the test sample, and amplifying a target region of the extracted DNA by PCR, and c) the step of analyzing an amplification product.

Abstract: A major object of the present technology is to provide a technology for obtaining an aloe extract which has an excellent processability into foods and contains sufficient amounts of ?-sitosterol and aloe-derived dietary fibers as functional components. The present technology provides a method for manufacturing an aloe extract containing ?-sitosterol, phospholipids, and dietary fibers which involves carrying out: a homogenization step for homogenizing an aloe mesophyll solution; an enzymatic degradation step for adding a polysaccharide-degrading enzyme to the homogenized aloe mesophyll solution and degrading polysaccharides contained in the aforementioned homogenized aloe mesophyll solution; and a membrane filtration step for membrane-filtering the enzyme-degraded aloe mesophyll solution with a microfiltration membrane or an ultrafiltration membrane and recovering the retentate fraction as an aloe extract.

Abstract: An extract of Citrus depressa, preferably an organic solvent extract of a fruit and/or leaf of Citrus depressa, a supercritical extract of a fruit and/or leaf of Citrus depressa, or a subcritical extract of a fruit and/or leaf of Citrus depressa, containing 0.3 mass % or more of a polymethoxyflavonoid in terms of solid matter, for example, 0.2 mass % or more of nobiletin and/or 0.1 mass % or more of tangeretin in terms of solid matter, or a polymethoxyflavonoid, such as nobiletin and tangeretin, is used as an active ingredient of a muscle atrophy inhibitor.

Abstract: An electrolysis water-making apparatus (1) generates electrolyzed products by supplying a raw material solution into an electrolytic cell (4) to perform electrolysis, and generates electrolyzed water by diluting the electrolyzed products. The electrolysis water-making apparatus (1) includes a casing (20) configured to accommodate the electrolytic cell (4), and a bracket (30) fixed to the casing (20) in a freely detachable manner, and the bracket (30) includes a pair of rigid walls to which one end and the other end of the electrolytic cell (4) are attached. The pair of rigid walls have a dimension therebetween that can be adjusted according to the linear dimension of the electrolytic cell (4).

Abstract: The invention relates to an electrolysis water-making apparatus where an electrolytic cell in which a unit cell is provided in a casing, is fixed to an installation base by a fixture attached to the electrolytic cell, and, through a pipe group, electrolyte solution is supplied into the electrolytic cell, and electrolyzed products produced in the electrolytic cell are delivered. The electrolysis water-making apparatus is characterized in that: in the installation base, there are formed one or two or more through holes, depending on the size of the electrolytic cell, through which through hole the end part of the fixture can be inserted; an end part of the fixture is inserted through a through hole, which is selected from the one or two or more through holes depending on the size of the electrolytic cell; and an end part of the fixture which projects from the installation base is locked on the installation base.

Abstract: The electrolysis water-making apparatus (A) which is an apparatus for making electrolysis water (W5) by electrolyzing a raw material solution (W1, W3) including a chlorine ion includes: an electrolytic cell (2); a raw material solution feed pump (3) used to supply the raw material solution (W1, W3) to the electrolytic cell (2); and a pipe (32, 36) connecting an outlet (3b) of the raw material solution feed pump (3) allowing the raw material solution (W1, W3) to be discharged therefrom and an inlet (26) allowing the raw material solution (W1, W3) to flow into the electrolytic cell (2). In addition, the raw material solution feed pump (3) is provided so that the outlet (3b) is disposed on a lower side of the inlet (26).